Where our
relationships
compound.
JINS Capital operates inside four verticals — sectors where our co-founders have lived as operators, attorneys, bankers, and advisors. We do not chase categories; we deepen the rooms we already sit in. Each vertical is led by a partner with first-hand experience, and each mandate is selected for fit, not for fee.
Pro
Sports.
A vertical built on four decades inside the room. Our partner's tenure as the Official Statistician for the Philadelphia 76ers — every game since 1988 — is the kind of relationship sports capital is actually moved by.
We work across teams, franchises, and athlete-led ventures — from minority limited-partner stakes through to operating partnerships. The introduction is always relationship-led.
JINS sits at the intersection of league office, ownership group, and the small handful of family offices and sovereigns who actually clear into the cap table. We support minority recapitalisations, expansion-franchise conversations, and athlete-founder platforms where the founder's brand is the strategic moat.
Beyond the team itself: women's sports, esports, training-and-performance technology, sports media rights, and the venues that surround them — selected only where our partner's bench can credibly underwrite operator quality.
Real
Estate.
The vertical where JINS most often begins a relationship. Led by a real-estate attorney and broker, we elevate distinctive assets to a curated universe of investors — and source the same for the families who allocate alongside us.
We work across the full commercial and luxury residential stack — supporting transactions with the rigour of a top-tier attorney and the discretion of a luxury broker.
Mandates range from multi-hundred-million-dollar recapitalisations to single-asset trophy acquisitions. We represent UHNW individuals, family offices, institutional investors, lenders, developers, and operators — typically on the buy-side, often on the sell-side, and frequently as the discreet intermediary when both parties are inside our network.
Our edge is twofold: access to opportunities that are not openly marketed, and structure — capital stacks, joint-venture terms, and cross-border vehicles designed to protect long-term ownership rather than maximise short-term fees.
Medical
Technology.
Late-stage clinical assets and commercial-stage platforms — where the science is settled, but the path to scale still needs patient, institutional capital and disciplined commercial guidance.
We focus on the back half of the medical-technology lifecycle — assets de-risked enough to underwrite, but not yet at the scale where the public markets are the obvious answer.
Mandates include late-stage device companies approaching commercial inflection, therapeutic platforms with regulatory clarity and a defined go-to-market, and category-defining specialty operators consolidating fragmented sub-markets. We support founder-CEOs and PE-backed teams through growth equity, strategic partnerships, and selective M&A.
Our network bridges patient capital, strategic acquirers, and the operator-clinicians who actually run these companies. We work alongside specialist healthcare funds — not in competition with them — when an introduction or co-investment is the right fit for both sides.
Opportunistic
Tech.
A deliberately narrow vertical. We participate only where our network — institutional banking, strategy, and operator relationships — converts into access or terms the broader market cannot match.
We do not run a venture book. We run a special-situations book — late-stage equity, secondaries, structured primaries, and select cross-border opportunities where the introduction is the alpha.
Typical engagements include late-stage growth rounds where our LPs receive allocation that would otherwise clear among a small circle of funds; employee and founder secondaries ahead of public listings; structured PIPEs and primaries for category-leading public-market candidates; and cross-border platforms where our partner's strategy background opens market access.
Sectors are deliberately broad — fintech, enterprise software, AI infrastructure, climate, and consumer at scale — but the filter is constant: an asset our network can credibly underwrite and a relationship that earns the cap-table seat.